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SUPPRESSION OF SEBACEO[JS GLAND ACTIVITY WITH
EICOSA-5 :8:11: 14-TETRAYNOIC ACID*
JOHN S. STRAUSS, M.D., PETER E. PocHI, M.D. AND
ERWIN N. WHITMAN, M.D.
In the testing of compounds which inhibit choles-
terol synthesis, it was found that eicosa-5:8:l1:14-
tetraynoic acid [CH3( CH2)4( CCCH2)4( Cl2)2
COOn], which blocks the pathway of cholesterol
synthesis between acetate and mevalonic acid (1),
exerted a suppressive effect on sebaceous gland
secretion. This report describes these preliminary
MATERIAL AND METHOD
Sixteen males, age 20 to 45, were given oral doses
of eicosa-5:8: 11: 14-tetraynoic acid for periods
ranging from 7½ to 10 weeks. Dosage varied from
0.5 to 2.0 gm daily. Eight subjects (nos. 1—8) were
normal volunteers; eight subjects (nos. 9—16) had
TABLE I
studies of the effect on sebum production in man
from the oral administration of this unsaturated
fatty acid.
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acne of a moderate to severe degree; one of these
subjects (no. 12) had acne rosacea with severe
rhinophyma. Sebum production was measured on
repeated occasions before and every one to four
weeks during drug administration using a method
described elsewhere (2). Statistical analyses were
done by the methods of paired comparison.
RESULTS
The results for the individual subjects are shown
in Table I in which mean values for all pre-treat-
ment and all post-treatment sebum tests were cal-
culated for each individual. Every subject showed
a decrease in sebum production, ranging from
13.1% to 63.9%. In 11 of the 16 subjects the de-
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Sebum production in male subjects administered eicosa-5 :8:11 : 14-tetraynoic acid
s bU jec Daily dose(gm) Treatment period(weeks)
Sebum production(mg lipid/b sq cm/3 hours)
treent Treatment % Decrease
Normal 1
2
3
4
5
6
7
8
1.5
1.5
1.5
1.0
2.0
2.0
0.5—2.0
0.5—2.0
8
99
9
10
12
16
14
4.29
2.14
3.41
1.42
1.57
2.29
2.05
4.35
1.98
1.13
2.34
0.98
1.12
1.67
1.57
3.78
54.3
47.2
31.4
31.0
28.7
27.1
23.4
13.1
Acne 9
10
11
12
13
14
15
16
1.5
1.0
1.5
.75—1.0
1.0
1.5
1.5
1.5
7
10
11
19
13
10
118
2.69
4.82
4.43
3.25
4.08
2.86
2.94
4.73
0.97
1.95
1.93
1.47
1.88
1.32
1.40
3.49
63.9
59.5
56.4
54.8
53.9
53.8
52.4
26.2
SEBACEOUS GLAND SUPPRESSION 493
TABLE II
Group analysis of sebum production response to
eicosa-5:8:11: 14-teiraynoic acid
Sebuns production
(mg lipid/tO sq cm/3 hours)
Significance
Pre- %
-
Treat- Decreasetreat I mentment i
Normal
subjects
Acne subjects
All subjects
2.74 1.89
3.72 1.80
3.20 1.85
32.3
51.6
44.2
p < .01
p < .001
p < .001
crease in sebum exceeded 30%, with only one
(subject 8) showing less than a 20% fall in sebum
output. As indicated in Table II, the average sup-
pression of 32.3% in the normal subjects and of
51.6% in the acne patients was highly significant
for each group (p < .01 and p < .001, respec-
tively). The average reduction in sebum secretion
for all the individuals studied was 442% (p <
.001).
There were seven subjects with acne vulgaris
and one with acne rosacea. Although their num-
bers were too few to allow for definitive conclu-
sions, it was observed in every case that the ac-
tivity of the disease was either much reduced or
abolished once sebaceous suppression had been
achieved.
SUMMARY
The oral administration of eicosa-5:8:11:14-
tetraynoic acid, an unsaturated fatty acid, pro-
duced a decrease in sebum production in each of
16 male subjects studied. The average reduction in
sebum secretion was 442%, and this was highly
significant (p < .001).
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